Literature DB >> 4310438

Antilymphocytic serum in experimental allergic encephalomyelitis.

E J Field.   

Abstract

Antilymphocytic and antithymic sera (raised in rabbits) are highly potent in preventing or alleviating experimental allergic encephalomyelitis in guinea-pigs. Good results are obtained when treatment is begun as late as 10 days after challenge. No protracted disease was seen from the use of antilymphocytic serum. Attempts to use this serum therapeutically once the disease was clinically established gave equivocal results. Antilymphocytic serum appears to have a non-specific stressor effect as well as its specific action, and possibly this adrenocorticotrophic-hormone (antiphlogistic) effect may ameliorate a developing encephalitis. The presence of an antimacrophagic factor in antilymphocytic serum may be important in increasing local reaction to injection of the serum and perhaps also in diminishing the appearance of haematogenous elements in the nervous lesions.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4310438      PMCID: PMC1984650          DOI: 10.1136/bmj.3.5673.758

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  AN ENCEPHALITOGENIC PROTEIN OF HUMAN ORIGIN: SOME CHEMICAL AND BIOLOGICAL PROPERTIES.

Authors:  E A CASPARY; E J FIELD
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Dialysable peptide as the causative factor in experimental "allergic" encephalomyelitis.

Authors:  D M ROBERTSON; R BLIGHT; C E LUMSDEN
Journal:  Nature       Date:  1962-12-08       Impact factor: 49.962

3.  Occurrence of lipemia in experimental allergic encephalomvelitis.

Authors:  M W KIES; N P GOLDSTEIN; J B MURPHY; E ROBOZ; E C ALVORD
Journal:  Neurology       Date:  1957-03       Impact factor: 9.910

4.  Evidence for the production of circulating antibodies by homografts of lymphoid tissue and skin.

Authors:  M F A WOODRUFF; B FORMAN
Journal:  Br J Exp Pathol       Date:  1950-06

5.  Central and peripheral effects of anti-lymphocyte sera.

Authors:  J L Turk; D A Willoughby
Journal:  Lancet       Date:  1967-02-04       Impact factor: 79.321

6.  Anti-macrophage component of antilymphocytic serum.

Authors:  E J Field; D Hughes
Journal:  Lancet       Date:  1969-04-26       Impact factor: 79.321

7.  The effect of anti-lymphocyte serum on experimental allergic encephalomyelitis in the guinea-pig.

Authors:  S Leibowitz; M H Lessof; L A Kennedy
Journal:  Clin Exp Immunol       Date:  1968-10       Impact factor: 4.330

Review 8.  Experimental allergic encephalomyelitis and autoimmune disease.

Authors:  P Y Paterson
Journal:  Adv Immunol       Date:  1966       Impact factor: 3.543

9.  Stress effect of antilymphocyte serum.

Authors:  E J Field; D B Cook
Journal:  Br Med J       Date:  1969-04-26

10.  The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type.

Authors:  B H WAKSMAN; S ARBOUYS; B G ARNASON
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  2 in total

1.  Lymphocyte sensitization to nervous tissues and muscle in patients with the Guillain-Barré syndrome.

Authors:  E A Caspary; S Currie; J N Walton; E J Field
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-04       Impact factor: 10.154

2.  The effect of anti-lymphocytic antibody on the development of experimental thyroiditis in rats induced by the intra-lymph node injection of rat thyroglobulin in Freund's complete adjuvant.

Authors:  J R Kalden; K James
Journal:  Immunology       Date:  1971-03       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.